Huaren Pharmaceutical Co., Ltd. (300110.SZ)
CNY 3.77
(-0.53%)
CNY 3.77
(-0.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 305.59 Million | 217.98 Million | -578.52 Million | -10.74 Million | 309.33 Million | 254.31 Million |
| Net Income | 193.42 Million | 181.33 Million | 134.05 Million | 96.88 Million | 45.16 Million | 37.46 Million |
| Depreciation & Amortization | 126.85 Million | 149.58 Million | 134.94 Million | 113.44 Million | 116.38 Million | 116.35 Million |
| Deferred income taxes | 10.62 Million | -15.44 Million | -9.34 Million | -119.68 Thousand | -6.6 Million | -3.2 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -102.22 Million | -232 Million | -1.01 Billion | -298.01 Million | 30.06 Million | 14.85 Million |
| Other non-cash items | 70.06 Million | 119.06 Million | 167.31 Million | 76.93 Million | 117.72 Million | 85.64 Million |
| Investing Cash Flow | -97.13 Million | -143.81 Million | -458.58 Million | -237.96 Million | 5.46 Million | -55.17 Million |
| Investments in PPE | -45.86 Million | -42.32 Million | -27.85 Million | -57.96 Million | -32.01 Million | -45.47 Million |
| Acquisitions | -61.6 Million | -128 Million | -431.8 Million | -186.34 Million | 114.28 Thousand | 7.16 Million |
| Investment purchases | - | 0.41 | 1.72 | -14 Million | -24.5 Million | -310 Thousand |
| Sales/Maturities of investments | 301.57 Thousand | 87.09 Thousand | 1 Million | 16.96 Million | 21.66 Million | 11.57 Million |
| Other Investing Activities | 10.32 Million | 26.43 Million | 68.89 Thousand | 3.37 Million | 40.21 Million | -28.12 Million |
| Financing Cash Flow | -120.72 Million | -152.66 Million | 1.04 Billion | 112.34 Million | -576.41 Million | 270.38 Million |
| Debt repayment | -108.26 Million | -2.17 Billion | -694 Million | -202.7 Million | -734.9 Million | -843.53 Million |
| Dividends payments | -24.82 Million | -21.27 Million | -17.72 Million | -11.82 Million | -35.46 Million | -55.55 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 76.06 Million | 2.11 Billion | 1.8 Billion | 337.5 Million | 216.98 Million | 1.16 Billion |
| Accounts receivables | 9.01 Million | 135.83 Million | -1.3 Billion | -345.46 Million | 9.32 Million | 97.95 Million |
| Accounts payables | -63.84 Million | -361.01 Million | 303.49 Million | 81.31 Million | 33.09 Million | -81.35 Million |
| Inventory | -58.03 Million | 8.62 Million | -2.18 Million | -33.74 Million | -5.76 Million | 1.45 Million |
| Other working capital | -53.21 Million | -15.44 Million | -9.34 Million | -119.68 Thousand | -6.6 Million | 13.4 Million |
| Cash at beginning of period | 144.13 Million | 222.62 Million | 219.59 Million | 355.92 Million | 617.23 Million | 148 Million |
| Cash at end of period | 231.86 Million | 144.13 Million | 222.62 Million | 219.59 Million | 355.92 Million | 617.23 Million |
| Capital Expenditure | -45.86 Million | -42.32 Million | -27.85 Million | -57.96 Million | -32.01 Million | -45.47 Million |
| Effect of forex changes on cash | -1405.60 | -895.71 | -16.65 Thousand | 29.47 Thousand | 306.88 Thousand | -287.37 Thousand |
| Net cash flow / Change in cash | 87.73 Million | -78.49 Million | 3.03 Million | -136.32 Million | -261.3 Million | 469.23 Million |
| Free Cash Flow | 259.73 Million | 175.65 Million | -606.37 Million | -68.7 Million | 277.31 Million | 208.84 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22.31 Million | 22.39 Million | 50.82 Million | 50.97 Million | 193.42 Million | 54.8 Million |
| Depreciation & Amortization | - | 32.41 Million | 32.41 Million | 126.85 Million | 126.85 Million | -58.15 Million |
| Deferred income taxes | - | - | - | - | 10.62 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 37.7 Million | - | -49.01 Million | -102.22 Million | 90.5 Million |
| Other non-cash items | 101.76 Million | 60.81 Million | 59.69 Million | -20.28 Million | 70.06 Million | -15.43 Million |
| Investing Cash Flow | -17.61 Million | -7.64 Million | -12.04 Million | -11.88 Million | -97.13 Million | -9.81 Million |
| Investments in PPE | -3.94 Million | -7.65 Million | -12.04 Million | -11.88 Million | -45.86 Million | -9.81 Million |
| Acquisitions | -13.67 Million | 5000.00 | - | 2752.28 | -61.6 Million | 2.37 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 301.57 Thousand | -301.57 Thousand |
| Other Investing Activities | - | 5000.00 | - | 2752.00 | 10.32 Million | -2.07 Million |
| Financing Cash Flow | -98.49 Million | -40.64 Million | -221.12 Million | -18.57 Million | -120.72 Million | -179.31 Million |
| Debt repayment | -63.18 Million | -19.29 Million | -206.11 Million | -49.86 Million | -108.26 Million | -430.76 Million |
| Dividends payments | -24.82 Million | -24.82 Million | -15.01 Million | -24.82 Million | -24.82 Million | -42.31 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -60.13 Million | 3.46 Million | -15.01 Million | 46.25 Million | 76.06 Million | 293.76 Million |
| Accounts receivables | - | 22.14 Million | - | 9.01 Million | 9.01 Million | 59.67 Million |
| Accounts payables | - | - | - | - | -63.84 Million | - |
| Inventory | - | 15.56 Million | - | -58.03 Million | -58.03 Million | 30.83 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 114.51 Million | 109.21 Million | 200.23 Million | 153.78 Million | 144.13 Million | 271.51 Million |
| Cash at end of period | 120.1 Million | 111.7 Million | 112.16 Million | 231.86 Million | 231.86 Million | 153.78 Million |
| Capital Expenditure | -3.94 Million | -7.65 Million | -12.04 Million | -11.88 Million | -45.86 Million | -9.81 Million |
| Effect of forex changes on cash | - | -1974.47 | -1520.60 | 564.46 | -1405.60 | -1697.50 |
| Net cash flow / Change in cash | 5.58 Million | 2.49 Million | -88.06 Million | 78.07 Million | 87.73 Million | -117.73 Million |
| Free Cash Flow | 120.13 Million | 43.13 Million | 98.47 Million | 96.65 Million | 259.73 Million | 61.89 Million |
DPUM
GGPS3
HKMPY
TUPY3
SHIEF
AURUM